Australie - anglais - Department of Health (Therapeutic Goods Administration)

yarra vibe pty ltd - calcium citrate tetrahydrate, quantity: 1 g (equivalent: calcium, qty 200 mg); magnesium oxide, quantity: 67.11 mg (equivalent: magnesium, qty 40 mg); menaquinone 7, quantity: 20 microgram; manganese amino acid chelate, quantity: 10 mg (equivalent: manganese, qty 1 mg); colecalciferol, quantity: 0.004 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; povidone; silicon dioxide; croscarmellose sodium; hypromellose; macrogol 400; titanium dioxide; carnauba wax; maize starch; dl-alpha-tocopherol; sucrose; hydrolysed gelatin; hydrogenated soya oil - maintain/support general health and wellbeing ; maintain/support healthy teeth ; maintain/support teeth mineralisation ; maintain/support teeth strength ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support bone mass/density/integrity ; maintain/support (state mineral) absorption in bones ; maintain/support bone strength ; help maintain/support bone mineralisation ; a diet deficient in calcium can lead to osteoporosis in later life. calcium may help prevent osteoporosis when dietary intake is inadequate ; vitamin d helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; maintain/support muscle health ; maintain/support muscle function ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml;  ;   - solution for injection - 300 mg/30ml - active: calcium folinate 10.5 mg/ml     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml (4% overage);  ;   - solution for injection - 50 mg/5ml - active: calcium folinate 10.5 mg/ml (4% overage)     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 18.6mg equivalent to folinic acid 15 mg - tablet - 15 mg - active: calcium folinate 18.6mg equivalent to folinic acid 15 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride dihydrate; phenylalanine; histidine; arginine; alanine; threonine; tryptophan; tyrosine; valine; glycine; methionine; isoleucine; lysine; magnesium chloride hexahydrate; serine; leucine; proline; sodium chloride; sodium lactate - solution for peritoneal dialysis - calcium chloride dihydrate 184 mg/l; phenylalanine 570 mg/l; histidine 714 mg/l; arginine 1071 mg/l; alanine 951 mg/l; threonine 646 mg/l; tryptophan 270 mg/l; tyrosine 300 mg/l; valine 1393 mg/l; glycine 510 mg/l; methionine 850 mg/l; isoleucine 850 mg/l; lysine 955 mg/l; magnesium chloride hexahydrate 51 mg/l; serine 510 mg/l; leucine 1020 mg/l; proline 595 mg/l; sodium chloride 5380 mg/l; sodium lactate 4480 mg/l - blood substitutes and perfusion solutions

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 20 g/l; magnesium chloride hexahydrate 0.068 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 9.29 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.343 g/l; glucose monohydrate 33.3 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 21.12 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 4.48 g/l - blood substitutes and perfusion solutions

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.257 g/l; glucose monohydrate 42.5 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.67 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.12 g/l - blood substitutes and perfusion solutions

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.184 g/l; glucose monohydrate 15 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 5.38 g/l; sodium hydrogen carbonate 2.1 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

Malte - anglais - Medicines Authority

baxter healthcare limited - calcium chloride; glucose monohydrate; magnesium chloride hexahydrate; sodium chloride; sodium hydrogen carbonate; sodium lactate - solution for peritoneal dialysis - calcium chloride 0.507 g/l; glucose monohydrate 68.85 g/l; magnesium chloride hexahydrate 0.051 g/l; sodium chloride 8.43 g/l; sodium hydrogen carbonate 3.29 g/l; sodium lactate 1.68 g/l - blood substitutes and perfusion solutions